Let Activefol.io Invest in BMRN on Your Behalf.

Stock Detail Header
  • Active Investing
  • Personalized Strategy
  • Low Monthly Fees
Get Started
Stock Details
  • PRICE$69.00
  • % CHANGE1.56%


Course of Action


Sentiment (10 days)

  •  Strong Buy
  •  Buy
  •  Hold
  •  Sell
  •  Strong Sell


  • BullishBullish
  • BearishBearish
  • SentimentSentiment
  • BarPrice

Why Does Investing Using an Automated Portfolio Management Works?

Activefol.io is an advanced system designed to automate securities investing. It is designed to screens, monitors and auto-trades elite stocks like "BIOMARIN PHARMACEUTICAL INC. (BMRN)" using its proprietary Artificial Intelligence. By using Activefol.io an investor augments its potential to accelerate his financial performance.

Recommended Usage

Converting your 401k to a Rollover IRA and systematically invest using ACTIVEFOL.IO from Stock Circles could be a great strategy to grow your retirement account while you still have a long horizon before retirement. Activefol.io proprietary portfolio manager invests in Large Cap US Stocks only to ensure that you are investing in highly liquid securities.

Based on historical performance, Activefol.io's model strategies historically outperformed the S&P since 2016. It holds the potential to grow retirement accounts quicker than passive investment vehicles using the same securities.Activefol.io provides systematic investment strategies that use price momentum to produce short-term trades to build wealth.

In the past 3 years, the system has outperformed the S&P. Activefol.io makes short-term trades. If these trades happen in a tax-deferred account, you do not get taxed until you start taking money out of the account. So if you start auto-trading today in your retirement account and invests for 10, 15, 20 years, imagine how much money a systematic strategy as the potential to create for you.

This investment system works great for tax-deferred accounts like Traditional and Roth IRAs. You can trade with a minimum of $25,000 in your account.

Activefol.io is very affordable. You will pay a low monthly management fee to use it. Using Activefol.io will usually pay for itself on the first successful trade of the month.

Systematic investing is powerful

Systematic investing with ACTIVEFOL.IO is easy. You do not need to know anything about stock investing. All you need to do is to set up your trading strategy and the automated portfolio manager will take care of the rest. Stock Circles offers a default strategy to help you get started. You can test the strategy in simulation mode free of charge today. Once comfortable with the outcome, suitable investors are ready to invest real money. You can then connect Activefol.io to your brokerage account and start to auto-trade.

Past performance does not guarantee future success. Activefol.io will do its best to take advantage of the market but if the market goes down for a long period of time then there is no money to be made and everyone holding these securities can be affected.

Activefol.io invests only elite stocks. By investing in the S&P 500®, Nasdaq 100™ and Dow 30™.

Activefol.io uses Artificial Intelligence concepts to screen, monitor and invest in securities. It monitors and invests on your behalf while you attend more important life events.

Take advantage of active investing strategies today by registering at stockcircles.com It's free to start in simulation mode.


There are clear benefits associated with Activefol.io to help you reach your financial goals. Activefol.io simplifies stock investing down to a few steps. It invests for you, using your personalized strategy, while you attend more important life events.

Using Activefol.io is like having a professional portfolio manager working for you to help you reach your financial goals.

Activefol.io actively trades which is different from passive investing. The platform is on the lookout working to maximize your potential every minute of every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.

Activefol.io is one of the first automated portfolio managers to take advantage of Government grade listening technology that produces emotional and rational indicators.

Try Activefol.io today!

You can test your strategy in simulation mode, risk free, Stock Circles today.

Get started now - and see where active automated trading can take you.

Disclaimer: Past performance may not be indicative of future results. Activefol.io like other investment methods rely on favorable market conditions to provide positive outcomes.


BioMarin Named To Forbes List Of America's Best Mid-size Employers

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that it has been ranked 51st overall among 500 companies on Forbes magazine's 2018 list of "America's Best Mid-size Employers," and third among companies in the biotechnology industry. For more than 20 years, BioMarin has been focused on making a big difference for small patient populations by rapidly developing first-in-class or best-in-class therapies to treat rare genetic diseases.

"Forbes seeks to discover which companies operating in the U.S. today are best at making their employees feel happy, inspired, and well-compensated," Forbes explained in presenting a list of 500 mid-size employers selected from about 2,000 companies.

This is the first year that BioMarin has received the distinction of being included on the Forbes list of "America's Best Mid-size Employers," which recognizes the deep commitment of BioMarin employees to the rare disease communities they serve. Forbes has also recognized BioMarin on its "Most Innovative Companies" list for the past four consecutive years where it has been ranked in the top 12 each year.

"Being named by Forbes as a Best Employer is a source of pride for all of us at BioMarin. This recognition combined with being named a top 20 company on Forbes Most Innovative Companies list over the last four years highlights important attributes that attract and engage employees, who share a commitment to each other and the rare disease patients we serve," said Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin.

"Our people are the most valuable resources we have, and this honor from Forbes is a testament to BioMarin's commitment to creating and fostering a work environment where people can flourish while making a big difference in small patient populations," said Rich Ranieri, Executive Vice President, Human Resources. "Individuals come to BioMarin to be scientific pioneers in rare disease, and they stay because they are making a big impact on the lives of patients and their families."

Get Started today! - Risk Free

Investors who like BIOMARIN PHARMACEUTICAL INC. (BMRN) also like

Most Talked About Stocks on Stock Circles

Stock Bubbles